Skip to main content
logo
Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
3.090
-0.020 (-0.64%)
Aug 31, 2026, 11:28 AM EDT - Market open

Altimmune Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.030.040.020.43-0.074.41
Revenue Growth
55.00%105.00%-95.30%---46.12%
Gross Profit
-66.69-66.39-82.21-65.37-70.52-69.43
Operating Income
-98.73-94.49-103.17-83.51-87.65-84.84
Net Income
-91.76-88.09-95.06-88.45-84.71-97.09
Earnings Per Share
-0.73-1.00-1.34-1.66-1.81-2.35
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
326.28273.46131.89197.82184.88190.3
Total Debt
36.0235.691.680.671.121.54
Net Cash (Debt)
290.26237.77130.21197.14183.76188.77
Net Cash Growth
73.54%82.60%-33.95%7.29%-2.65%-11.83%
Net Cash Per Share
2.302.701.833.703.924.57

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-76.51-67.54-79.85-75.81-62.59-78.24
Capital Expenditures
-0.05-0.01--0.05-0.13-12.12
Free Cash Flow
-76.56-67.55-79.85-75.86-62.71-90.36
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
-318493.55%-230460.98%-515860.00%-19603.29%--1923.90%
Pretax Margin
-296000.00%-216521.95%-475295.00%-20762.21%124867.65%-2201.59%
Profit Margin
-296000.00%-214860.98%-475295.00%-20762.21%--2201.59%
FCF Margin
-246974.19%-164746.34%-399240.00%-17806.81%--2048.87%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-3.913.913.913.913.91
PS Ratio
19514.529610.9725640.431418.90-11888.9082.35